Literature DB >> 25126491

Personalized medicine approach in mycobacterial disease.

Mehdi Mirsaeidi1.   

Abstract

Mycobacterial diseases are a group of illnesses that cause a considerable number of deaths throughout the world, regardless of years of public health control efforts. Personalized medicine is a new but rapidly advancing field of healthcare. Personalized medicine in the field of mycobacteriology may be applied in the different levels of management such as prevention, diagnosis, treatment and prognosis. A genetic predisposition and a protein dysfunction study are recommended to tailor an individual approach in mycobacterial diseases.

Entities:  

Keywords:  Mycobacterial; NTM; Personalized medicine; TB

Year:  2012        PMID: 25126491      PMCID: PMC4130370          DOI: 10.1016/j.ijmyco.2012.03.001

Source DB:  PubMed          Journal:  Int J Mycobacteriol        ISSN: 2212-5531


  40 in total

1.  Analysis of IL1B, TAP1, TAP2 and IKBL polymorphisms on susceptibility to tuberculosis.

Authors:  L M Gomez; J F Camargo; J Castiblanco; E A Ruiz-Narváez; J Cadena; J M Anaya
Journal:  Tissue Antigens       Date:  2006-04

Review 2.  Genome-wide association studies for common diseases and complex traits.

Authors:  Joel N Hirschhorn; Mark J Daly
Journal:  Nat Rev Genet       Date:  2005-02       Impact factor: 53.242

3.  Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries.

Authors:  Jennifer Adjemian; Kenneth N Olivier; Amy E Seitz; Steven M Holland; D Rebecca Prevots
Journal:  Am J Respir Crit Care Med       Date:  2012-02-03       Impact factor: 21.405

Review 4.  Nontuberculous mycobacteria: opportunistic environmental pathogens for predisposed hosts.

Authors:  James L Cook
Journal:  Br Med Bull       Date:  2010-10-25       Impact factor: 4.291

5.  Pulmonary mycobacterium Simiae infection and HTLV1 infection: an incidental co-infection or a predisposing factor?

Authors:  S M Mirsaeidi; P Tabarsi; A Mardanloo; G Ebrahimi; M Amiri; P Farnia; M Sheikhleslami; V Bakayev; F Mohammadi; S D Mansouri; M R Masjedi; A A Velayati
Journal:  Monaldi Arch Chest Dis       Date:  2006-06

6.  Polymorphisms of interferon-gamma and interferon-gamma receptor 1 genes and non-tuberculous mycobacterial lung diseases.

Authors:  Jung Hye Hwang; Eun Joo Kim; Won-Jung Koh; Su Yeon Kim; Shin-Hye Lee; Gee Young Suh; O Jung Kwon; Chang Seok Ki; Yongick Ji; Miyeon Kang; Duk-Hwan Kim
Journal:  Tuberculosis (Edinb)       Date:  2006-10-04       Impact factor: 3.131

7.  Toll-like receptor 2 polymorphisms and nontuberculous mycobacterial lung diseases.

Authors:  Yon Ju Ryu; Eun Joo Kim; Won-Jung Koh; Hojoong Kim; O Jung Kwon; Jung Hyun Chang
Journal:  Clin Vaccine Immunol       Date:  2006-07

8.  Depressed T-cell interferon-gamma responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy.

Authors:  C S Hirsch; Z Toossi; C Othieno; J L Johnson; S K Schwander; S Robertson; R S Wallis; K Edmonds; A Okwera; R Mugerwa; P Peters; J J Ellner
Journal:  J Infect Dis       Date:  1999-12       Impact factor: 5.226

9.  Human leukocyte antigen (HLA)-linked control of susceptibility to pulmonary tuberculosis and association with HLA-DR types.

Authors:  S P Singh; N K Mehra; H B Dingley; J N Pande; M C Vaidya
Journal:  J Infect Dis       Date:  1983-10       Impact factor: 5.226

Review 10.  Pharmacogenomics of anti-TB drugs-related hepatotoxicity.

Authors:  Puspita Das Roy; Mousumi Majumder; Bidyut Roy
Journal:  Pharmacogenomics       Date:  2008-03       Impact factor: 2.533

View more
  4 in total

Review 1.  Management of nontuberculous mycobacterial infection in the elderly.

Authors:  Mehdi Mirsaeidi; Maham Farshidpour; Golnaz Ebrahimi; Stefano Aliberti; Joseph O Falkinham
Journal:  Eur J Intern Med       Date:  2014-03-29       Impact factor: 4.487

2.  Nontuberculous Mycobacteria: Epidemiologic, Mycobacteriologic, and Clinical Aspects.

Authors:  Mehdi Mirsaeidi; Parissa Farnia; Ruxana Sadikot; Po-Ren Hsueh; Stefano Aliberti
Journal:  Biomed Res Int       Date:  2015-06-16       Impact factor: 3.411

Review 3.  Highlight on advances in nontuberculous mycobacterial disease in North America.

Authors:  Mehdi Mirsaeidi; Maham Farshidpour; Mary Beth Allen; Golnaz Ebrahimi; Joseph O Falkinham
Journal:  Biomed Res Int       Date:  2014-09-11       Impact factor: 3.411

4.  Exome Sequencing Identifies a Novel MAP3K14 Mutation in Recessive Atypical Combined Immunodeficiency.

Authors:  Nikola Schlechter; Brigitte Glanzmann; Eileen Garner Hoal; Mardelle Schoeman; Britt-Sabina Petersen; Andre Franke; Yu-Lung Lau; Michael Urban; Paul David van Helden; Monika Maria Esser; Marlo Möller; Craig Kinnear
Journal:  Front Immunol       Date:  2017-11-27       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.